Angiogenic competency of biodegradable hydrogels fabricated from polyethylene glycol-crosslinked tyrosine-derived polycarbonates

European Cells and Materials

Volumn 15, Issue , 2008, Pages 77-87

  Sung, H J ^a   Sakala Labazzo, K M ^a   Bolikal, D ^a   Weiner, M J ^a   Zimnisky, R ^a   Kohn, Joachim ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Angiogenesis; Degradation; Hydrogel; PEG crosslink; Tyrosine derived polycarbonates

Indexed keywords

BIOMATERIAL; DEAMINOTYROSINE; DEAMINOTYROSYLTYROSINE; DEAMINOTYROSYLTYROSINE ETHYL ESTER; MACROGOL; MACROGOL DIDEAMINOTYROSYLTYROSINE HYDRAZIDE; POLYCARBONATE; TYROSINE DERIVATIVE; ANGIOGENESIS MODULATOR; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; MACROGOL DERIVATIVE; POLY(DTE CO PEG CARBONATE); POLY(DTE-CO-PEG CARBONATE); POLY(ETHYLENE GLYCOL) DI DT HYDRAZIDE; POLY(ETHYLENE GLYCOL)-DI-DT-HYDRAZIDE; TYROSINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABLE IMPLANT; CELL FUNCTION; CONCENTRATION (PARAMETERS); CROSS LINKING; CYTOTOXICITY; HYDROGEL; IMPLANTATION; NONHUMAN; POROSITY; RAT; TISSUE GROWTH; ANIMAL; CELL CULTURE; CELL MOTION; CELL SURVIVAL; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TISSUE ENGINEERING;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; HUMANS; HYDRAZINES; HYDROGELS; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENE GLYCOLS; RATS; TISSUE ENGINEERING; TYROSINE;

EID: 45549104814     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v015a06     Document Type: Article

References (36)

1. Abramson S (2002) Selected bulk and surface properties and biocompatibility of a new class of tyrosine-derived polycarbonates. R.A161 2002, Biomedical Engineering, Rutgers-The State University of New Jersey, New Jersey Center for Biomaterials, 145 Bevier Road, Piscataway, New Jersey 08854.
2. Attawia MA, Uhrich KE, Botchwey E, Fan M, Langer R, Laurencin CT (1995) Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications. J Biomed Mater Res 29:1233-1240.
3. Bachetti T, Morbidelli L (2000) Endothelial cells in culture: a model for studying vascular functions. Pharmacol Res 42: 9-19.
4. Ballara SC, Miotla JM, Paleolog EM (1999) New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders. Int J Exp Pathol 80: 235-250.
5. Bernardini D, Nasulewic A, Mazur A, Maier JA (2005) Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Front Biosci 10: 1177-1182.
6. Bezemer JM, Oude Weme P, Grijpma DW, Dijkstra PJ, van Blitterswijk CA, Feijen J (2000) Amphiphilic poly(ether ester amide) multiblock copolymers as biodegradable matrices for the controlled release of proteins. J Biomed Mater Res 52: 8-17.
7. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN (1999) An in vitro model of angiogenesis: basic features. Angiogenesis 3: 335-344.
8. Black AF, Hudon V, Damour O, Germain L, Auger FA (1999) A novel approach for studying angiogenesis: a human skin equivalent with a capillary-like network. Cell Biol Toxicol 15: 81-90.
9. Cassell OC, Hofer SO, Morrison WA, Knight KR (2002) Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg 55: 603-610.
10. Chellat F, Tabrizian M, Dumitriu S, Chornet E, Magny P, Rivard CH, Yahia L (2000) In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex. J Biomed Mater Res 51: 107-116.
11. Eckardt H, Bundgaard KG, Christensen KS, Lind M, Hansen ES, Hvid I (2003) Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res 21: 335-340.
12. Ertel SI, Kohn J (1994) Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials. J Biomed Mater Res 28: 919-930.
13. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267: 10931-10934.
14. Gerber HP, Ferrara N (2000) Angiogenesis and bone growth. Trends Cardiovasc Med 10: 223-228.
15. Gupta MK, Qin RY (2003) Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9: 1144-1155.
16. Harper J, Klagsbrun M (1999) Cartilage to bone-angiogenesis leads the way. Nat Med 5: 617-618.
17. Hausman MR, Schaffler MB, Majeska RJ (2001) Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29: 560-564.
18. Jain RK, Schlenger K, Hockel M, Yuan F (1997) Quantitative angiogenesis assays: progress and problems. Nat Med 3: 1203-1208.
19. James K, Levene H, Parsons JR, Kohn J (1999) Small changes in polymer chemistry have a large effect on the bone-implant interface: evaluation of a series of degradable tyrosine-derived polycarbonates in bone defects. Biomaterials 20: 2203-2212.
20. Kidd KR, Nagle RB, Williams SK (2002) Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. J Biomed Mater Res 59: 366-377.
21. Kim SH, Won CY, Chu CC (1999) Synthesis and characterization of dextran-maleic acid based hydrogel. J Biomed Mater Res 46: 160-170.
22. Labazzo K (2004) Hydrogels Fabricated from PEG-Crosslinked Tyrosine-Derived Polycarbonates and their Angiogenic Potential for Tissue Engineering. Rutgers-The State University of New Jersey, Biomedical Engineering.
23. Levene H (1999) Analysis of tyrosine-derived novel synthetic polymer scaffold devices for guided tissue regeneration. R.L657 1999, Biomedical Engineering, Rutgers-The State University of New Jersey, New Jersey Center for Biomaterials, 145 Bevier Road, Piscataway, New Jersey 08854.
24. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23: 47-55.
25. Malich G, Markovic B, Winder C (1997) The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124: 179-192.
26. Montanez E, Casaroli-Marano RP, Vilaro S, Pagan R (2002) Comparative study of tube assembly in three-dimensional collagen matrix and on Matrigel coats. Angiogenesis 5: 167-172.
27. Papadimitriou E, Heroult M, Courty J, Polykratis A, Stergiou C, Katsoris P (2000) Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides. Biochem Biophys Res Commun 274: 242-248.
28. Papadimitriou E, Polykratis A, Courty J, Koolwijk P, Heroult M, Katsoris P (2001) HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides. Biochem Biophys Res Commun 282: 306-313.
29. Sieminski AL, Gooch KJ (2000) Biomaterial-microvasculature interactions. Biomaterials 21: 2232-2241.
30. Sung HJ, Meredith C, Johnson C, Galis ZS (2004) The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25: 5735-5742.
31. Tabata Y, Nagano A, Muniruzzaman M, Ikada Y (1998) In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials 19: 1781-1789.
32. Taylor MS, Daniels AU, Andriano KP, Heller J (1994) Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater 5: 151-157.
33. Tello-Montoliu A, Patel JV, Lip GY (2006) Angiogenin: a review of the pathophysiology and potential clinical applications. J Thromb Haemost 4: 1864-1874.
34. Yla-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J (2007) Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 49: 1015-1026.
35. Yu C, Kohn J (1999) Tyrosine-PEG-derived poly(ether carbonate)s as new biomaterials. Part I: synthesis and evaluation. Biomaterials 20: 253-264.
36. Zhao X, Harris JM (1998) Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein. J Pharm Sci 87: 1450-1458.